What tax-related transaction is disclosed in the Form 4 for GTM?

The Reporting Person had 11,542 shares withheld to cover tax liabilities associated with RSU vesting.

Did the Form 4 disclose the price for any share disposition?

Yes; shares withheld for taxes are shown at a price of $10.91 per share.

GTM Insider Filing: Multiple RSU Vestings and Tax Withholding Details

Q: How many restricted stock units vested for the CFO on 10/01/2025?

The filing shows vesting events converting RSUs of 1,555 , 223 , 764 , and 31,250 units into common stock on 10/01/2025 .

Q: What are the vesting schedules disclosed in the filing?

Vesting schedules: awards from 12/30/2022 , 3/23/2023 , and 10/25/2023 vest quarterly beginning 10/01/2024 ; the 9/10/2024 award has 25% vesting on 10/01/2025 and the remainder quarterly thereafter.

Filing Impact

(High)

Filing Sentiment

(Negative)

Form Type

Rhea-AI Filing Summary

Michael Graham O'Brien, Chief Financial Officer of ZoomInfo Technologies Inc. (GTM), reported multiple restricted stock unit vesting events effective 10/01/2025. The Form 4 records vesting conversions into common stock totaling 34,??292 shares (aggregate from multiple awards) and subsequent withholding of 11,542 shares to cover taxes at an indicated price of $10.91 per share. Following the reported transactions, the filing shows the Reporting Person beneficially owned 76,218, 87,760, and 93,750 shares across different award pools, with total reported holdings reflected in the tables.

The disclosure lists original grant dates (12/30/2022, 3/23/2023, 10/25/2023, 9/10/2024) and vesting schedules: quarterly installments beginning 10/01/2024 or 10/01/2025 depending on the grant. The Form 4 is signed by an attorney-in-fact on 10/03/2025.

Insider Trade Summary

33,792 shares exercised/converted

Mixed 9 txns

Insider O'Brien Michael Graham

Role CFO

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units	1,555	$0.00	--
Exercise	Restricted Stock Units	223	$0.00	--
Exercise	Restricted Stock Units	764	$0.00	--
Exercise	Restricted Stock Units	31,250	$0.00	--
Exercise	Common Stock	1,555	$0.00	--
Exercise	Common Stock	223	$0.00	--
Exercise	Common Stock	764	$0.00	--
Exercise	Common Stock	31,250	$0.00	--
Tax Withholding	Common Stock	11,542	$10.91	$126K

Holdings After Transaction: Restricted Stock Units — 7,774 shares (Direct); Common Stock — 55,523 shares (Direct)

Footnotes (1)

Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. Reflects shares withheld to cover the Reporting Person's tax liability in connection with the vesting of the restricted stock units reported herein. The Reporting Person received an original grant of restricted stock units on December 30, 2022, which vest in equal quarterly installments during the 27 months following October 1, 2024. The Reporting Person received an original grant of restricted stock units on March 23, 2023, which vest in equal quarterly installments during the 30 months following October 1, 2024. The Reporting Person received an original grant of restricted stock units on October 25, 2023, which vest in equal quarterly installments during the 36 months following October 1, 2024. The Reporting Person received an original grant of restricted stock units on September 10, 2024, which vest as follows: (a) 25% on October 1, 2025; and (b) the remainder of the award in equal quarterly installments during the 36 months following October 1, 2025.

Form 4 Insider Transactions: What Each Field Means →

10/03/2025 - 04:06 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

O'Brien Michael Graham

(Last)

(First)

(Middle)

C/O ZOOMINFO TECHNOLOGIES INC.,

330 W COLUMBIA WAY, FLOOR 8

(Street)

VANCOUVER

98660

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
ZoomInfo Technologies Inc. [ GTM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	CFO

3. Date of Earliest Transaction (Month/Day/Year)
10/01/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	10/01/2025		M⁽¹⁾		1,555	A	⁽¹⁾	55,523	D
Common Stock	10/01/2025		M⁽¹⁾		223	A	⁽¹⁾	55,746	D
Common Stock	10/01/2025		M⁽¹⁾		764	A	⁽¹⁾	56,510	D
Common Stock	10/01/2025		M⁽¹⁾		31,250	A	⁽¹⁾	87,760	D
Common Stock	10/01/2025		F⁽²⁾		11,542	D	$10.91	76,218	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Units	⁽¹⁾	10/01/2025		M⁽¹⁾			1,555	⁽³⁾	⁽³⁾	Common Stock	1,555	$0	7,774	D
Restricted Stock Units	⁽¹⁾	10/01/2025		M⁽¹⁾			223	⁽⁴⁾	⁽⁴⁾	Common Stock	223	$0	1,340	D
Restricted Stock Units	⁽¹⁾	10/01/2025		M⁽¹⁾			764	⁽⁵⁾	⁽⁵⁾	Common Stock	764	$0	6,116	D
Restricted Stock Units	⁽¹⁾	10/01/2025		M⁽¹⁾			31,250	⁽⁶⁾	⁽⁶⁾	Common Stock	31,250	$0	93,750	D

Explanation of Responses:

1. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock.

2. Reflects shares withheld to cover the Reporting Person's tax liability in connection with the vesting of the restricted stock units reported herein.

3. The Reporting Person received an original grant of restricted stock units on December 30, 2022, which vest in equal quarterly installments during the 27 months following October 1, 2024.

4. The Reporting Person received an original grant of restricted stock units on March 23, 2023, which vest in equal quarterly installments during the 30 months following October 1, 2024.

5. The Reporting Person received an original grant of restricted stock units on October 25, 2023, which vest in equal quarterly installments during the 36 months following October 1, 2024.

6. The Reporting Person received an original grant of restricted stock units on September 10, 2024, which vest as follows: (a) 25% on October 1, 2025; and (b) the remainder of the award in equal quarterly installments during the 36 months following October 1, 2025.

Remarks:

	/s/ Meredith Weisshaar, as Attorney-in-Fact	10/03/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What did ZoomInfo (GTM) CFO Michael O'Brien report on Form 4?

The Form 4 reports vesting of multiple restricted stock units on 10/01/2025, conversion into common stock, and withholding of 11,542 shares to cover taxes at $10.91 per share.

How many restricted stock units vested for the CFO on 10/01/2025?

The filing shows vesting events converting RSUs of 1,555, 223, 764, and 31,250 units into common stock on 10/01/2025.

What are the vesting schedules disclosed in the filing?

Vesting schedules: awards from 12/30/2022, 3/23/2023, and 10/25/2023 vest quarterly beginning 10/01/2024; the 9/10/2024 award has 25% vesting on 10/01/2025 and the remainder quarterly thereafter.